v3.25.0.1
Collaboration and License Agreements (Tables)
 3 Months Ended
Dec. 31, 2024
Collaboration And License Agreements [Abstract]  
Schedule of Revenue
The following table provides a summary of revenue recognized:
Three Months Ended December 31,
20242023
(in thousands)
GSK$2,500 $2,685 
Takeda— 866 
Total$2,500 $3,551 
Schedule of Receivables and Contract Liabilities
The following table summarizes the balance of receivables and contract liabilities related to the Company’s collaboration and license agreements:
December 31, 2024September 30, 2024
(in thousands)
Receivables included in accounts receivable$2,500 $— 
Contract liabilities included in deferred revenue$— $—